David R Ebsworth insider trades: Verona Pharma (VRNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | VRNA | ↓ Sell | 1,904 | $13.14 | $25K | Direct | Aug 5, 2025 (4d) |
| Nov 18, 2024 | VRNA | ↑ Buy | 20,000 | $4.44 | $89K | Direct | Nov 18, 2024 (0d) |
| Nov 6, 2024 | VRNA | ↑ Buy | 39,360 | $4.80 | $189K | Direct | Nov 7, 2024 (1d) |
| Aug 12, 2024 | VRNA | ↑ Buy | 36,000 | $2.87 | $103K | Direct | Aug 14, 2024 (2d) |
| Nov 6, 2023 | VRNA | ↑ Buy | 160,000 | $1.98 | $316K | Direct | Nov 8, 2023 (2d) |
| May 4, 2021 | VRNA | ↓ Sell | 11,184 | $0.84 | $9K | Direct | May 5, 2021 (1d) |
| Feb 1, 2021 | VRNA | ↓ Sell | 11,912 | $0.99 | $12K | Direct | Feb 3, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David R Ebsworth's insider trades
David R Ebsworth is a director at Verona Pharma (VRNA). Since Feb 1, 2021, David has reported 4 open-market purchases worth $697K and 3 sales worth $46K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), option exercises (4 filings), shares returned to the company (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.